FDA: Better warning labels for antidepressants and watch those taking them

03/23/2004 | HealthDay News · NYTimes.com

The FDA sent a letter to the manufacturers of 10 popular antidepressants asking them to beef up their labels to highlight possible serious side effects, including suicide. The FDA also urged doctors and parents to pay close attention to those taking the drugs, especially children. While the FDA said experts have not been able to state with certainty that it is use of the drugs, and not the condition itself, that causes behavioral changes, the administration said increased off-label use of the drugs by non-psychiatrists makes it important that the warnings be better known. Several drug makers said they were studying the request and would decide soon on how to react.

View Full Article in:

HealthDay News · NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC